Skip to Main Content

Author Details

Katelyn A Bruno
Mayo Clinic
2017
40
16
PMIDPaper TitleJournal TitlePublished Year
37597175Laryngological Complaint Prevalence in Hypermobile Ehlers-Danlos or Hypermobility Spectrum Disorders.Laryngoscope2024
36937911Sex and gender differences in myocarditis and dilated cardiomyopathy: An update.Front Cardiovasc Med2023
37859995Rates Among Hospitalized Patients With COVID-19 Treated With Convalescent Plasma: A Systematic Review and Meta-Analysis.Mayo Clin Proc Innov Qual Outcomes2023
37612820Reconstituted Extracellular Vesicles from Human Platelets Decrease Viral Myocarditis in Mice.Small2023
35687402The Impact of a Group Telemedicine Program for Chronic Disease: A Retrospective Cohort Survey Study on Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorder.Telemed J E Health2023
37181352High overlap in patients diagnosed with hypermobile Ehlers-Danlos syndrome or hypermobile spectrum disorders with fibromyalgia and 40 self-reported symptoms and comorbidities.Front Med (Lausanne)2023
36741845Sex and age differences in sST2 in cardiovascular disease.Front Cardiovasc Med2023
36456416Extracellular vesicles as personalized medicine.Mol Aspects Med2023
35096991Trpc6 Promotes Doxorubicin-Induced Cardiomyopathy in Male Mice With Pleiotropic Differences Between Males and Females.Front Cardiovasc Med2022
35811641Establishing an Ehlers-Danlos Syndrome Clinic: Lessons Learned.SN Compr Clin Med2022
35743613Upregulation of Endothelin-1 May Predict Chemotherapy-Induced Cardiotoxicity in Women with Breast Cancer.J Clin Med2022
35991633Sex differences in comorbidities associated with Sjögren's disease.Front Med (Lausanne)2022
36292038Cardiovascular Factors Associated with COVID-19 from an International Registry of Primarily Japanese Patients.Diagnostics (Basel)2022
36344142Late Treatment for COVID-19 With Convalescent Plasma.Chest2022
35013614Concerns about estimating relative risk of death associated with convalescent plasma for COVID-19.Nat Med2022
35155458The Role of Disease Severity and Demographics in the Clinical Course of COVID-19 Patients Treated With Convalescent Plasma.Front Med (Lausanne)2022
34164419Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence.Front Med (Lausanne)2021
33851175Program and patient characteristics for the United States Expanded Access Program to COVID-19 convalescent plasma.medRxiv2021
33501470The Role of Disease Severity and Demographics in the Clinical Course of COVID-19 Patients Treated with Convalescent Plasma.medRxiv2021
33523609Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19.N Engl J Med2021
34928960Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study.PLoS Med2021
34445539Sex-Specific Effects of Plastic Caging in Murine Viral Myocarditis.Int J Mol Sci2021
34042389A Novel Circulating MicroRNA for the Detection of Acute Myocarditis.N Engl J Med2021
34070351Sex Differences, Genetic and Environmental Influences on Dilated Cardiomyopathy.J Clin Med2021
34036587Use of convalescent plasma in COVID-19 patients with immunosuppression.Transfusion2021
33958057The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis.Mayo Clin Proc2021
32511566Early Safety Indicators of COVID-19 Convalescent Plasma in 5,000 Patients.medRxiv2020
32006209Myoglobin for Detection of High-Risk Patients with Acute Myocarditis.J Cardiovasc Transl Res2020
32861333Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients.Mayo Clin Proc2020
32655646Examination of Molecular Effects of <i>MYLK</i> Deletion in a Patient with Extensive Aortic, Carotid, and Abdominal Dissections That Underlie the Genetic Dysfunction.Case Rep Med2020
32903434Association of Genetic Variants at <i>TRPC6</i> With Chemotherapy-Related Heart Failure.Front Cardiovasc Med2020
32817978Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience.medRxiv2020
32525844Early safety indicators of COVID-19 convalescent plasma in 5000 patients.J Clin Invest2020
32198351Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity.Nat Commun2020
30638108Elevated Sera sST2 Is Associated With Heart Failure in Men ⿤50 Years Old With Myocarditis.J Am Heart Assoc2019
31551929BPA Alters Estrogen Receptor Expression in the Heart After Viral Infection Activating Cardiac Mast Cells and T Cells Leading to Perimyocarditis and Fibrosis.Front Endocrinol (Lausanne)2019
29669571Sex differences in pulmonary arterial hypertension: role of infection and autoimmunity in the pathogenesis of disease.Biol Sex Differ2018
30023283Type 1 sialidosis presenting with ataxia, seizures and myoclonus with no visual involvement.Mol Genet Metab Rep2018
28763429Genome-wide association study of cardiotoxicity in the NCCTG N9831 (Alliance) adjuvant trastuzumab trial.Pharmacogenet Genomics2017
29030406Sex Determines Cardiac Myocyte Stretch and Relaxation.Circ Cardiovasc Genet2017
  • 1 - 40 of 40

Recommended Authors

Yale University School
Career Start Year 2018
Number of shared co-authors 0
Department of Internal Medicine Yale School of Medicine New Haven CT.
Career Start Year 2018
Number of shared co-authors 0
NYU Langone Health and NYU School of Medicine
Career Start Year 2016
Number of shared co-authors 1
University of Arkansas for Medical Sciences
Career Start Year 2015
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 2013
Number of shared co-authors 0
Louis Stokes Cleveland VA Medical Center Cleveland
Career Start Year 2010
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 2009
Number of shared co-authors 0
Yale/YNHH Center for Outcomes Research and Evaluation (CORE)
Career Start Year 2008
Number of shared co-authors 0
University of Washington
Career Start Year 2008
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 2008
Number of shared co-authors 0
Cardiovascular Health Research Unit, University of Washington
Career Start Year 2008
Number of shared co-authors 0
National Institute of Diabetes and Digestive and Kidney Disease
Career Start Year 2007
Number of shared co-authors 0
National Intensive Care Evaluation Foundation
Career Start Year 2007
Number of shared co-authors 0
Stanford University
Career Start Year 2005
Number of shared co-authors 0
University of Missouri-Kansas City School of Medicine
Career Start Year 2003
Number of shared co-authors 0
Massachusetts General Hospital.
Career Start Year 2000
Number of shared co-authors 0
Cumming School of Medicine, University of Calgary, 0 Hospital Drive NW
Career Start Year 2000
Number of shared co-authors 0
Stanford University School of Medicine
Career Start Year 1999
Number of shared co-authors 0
Department of Quantitative Health Sciences Mayo Clinic Rochester MN USA.
Career Start Year 1999
Number of shared co-authors 0
Maastricht University Medical Centre
Career Start Year 1998
Number of shared co-authors 0
Yale Cardiovascular Research Center, Yale University School of Medicine
Career Start Year 1996
Number of shared co-authors 0
Stanford University
Career Start Year 1993
Number of shared co-authors 0
University of California San Diego (university of california san diego)
Career Start Year 1993
Number of shared co-authors 0
Institute for Precision Cardiovascular Medicine
Career Start Year 1992
Number of shared co-authors 0
and Blood Institute, National Institutes of Health
Career Start Year 1983
Number of shared co-authors 1
Mayo Clinic
Career Start Year 1983
Number of shared co-authors 5
Vanderbilt University School of Medicine
Career Start Year 1982
Number of shared co-authors 0
Biostatistics & Clinical Trial Center, Fondazione IRCCS Policlinico San Matteo
Career Start Year 1981
Number of shared co-authors 0
Department of Medicine and Cardiovascular Institute, Stanford University
Career Start Year 1978
Number of shared co-authors 0

Collaborators

Mayo Clinic
Co-authored papers 37
College of Human Medicine, Michigan State University
Co-authored papers 15
Mayo Clinic
Co-authored papers 15
University of Illinois at Urbana-Champaign
Co-authored papers 15
Mayo Clinic
Co-authored papers 14
Brock University
Co-authored papers 13
Mayo Clinic
Co-authored papers 13
Mayo Clinic
Co-authored papers 13
Johns Hopkins Bloomberg School of Public Health
Co-authored papers 12
Mayo Clinic
Co-authored papers 12
Division of Clinical Trials and Biostatistics, Mayo Clinic
Co-authored papers 8
Mayo Clinic
Co-authored papers 8
Mayo Clinic
Co-authored papers 8
Mayo Clinic
Co-authored papers 8
Mayo Clinic
Co-authored papers 8
Mayo Clinic
Co-authored papers 8
Mayo Clinic
Co-authored papers 8
Belarusian Medical Academy of Postgraduate Education, Belarusian State Medical University, Brest Medical College, Mayo Clinic, Mayo Graduate School
Co-authored papers 8
Mayo Clinic
Co-authored papers 8
Mayo Clinic
Co-authored papers 7
Mayo Clinic
Co-authored papers 7
The Spine & Pain Institute of New York
Co-authored papers 7
Mayo Clinic
Co-authored papers 7
Mayo Clinic
Co-authored papers 6
Mayo Clinic
Co-authored papers 6
Mayo Clinic Hospital
Co-authored papers 6
Center for Biologics Evaluation and Research
Co-authored papers 5
Mayo Clinic College of Medicine
Co-authored papers 5
Mayo Clinic
Co-authored papers 5
Albert Einstein College of Medicine, Montefiore Medical Center
Co-authored papers 4